Several analysts have recently updated their ratings and price targets for Blaize (NASDAQ: BZAI): 5/16/2026 – Blaize was downgraded by Wall Street Zen from “sell” to “strong sell”. 5/15/2026 – Blaize had its “buy” rating reaffirmed by Roth Mkm. They now have a $4.50 price target on the stock. 4/29/2026 – Blaize had its “buy” […]

Several brokerages have updated their recommendations and price targets on shares of Intellia Therapeutics (NASDAQ: NTLA) in the last few weeks: 5/16/2026 – Intellia Therapeutics was downgraded by Wall Street Zen from “hold” to “sell”. 5/13/2026 – Intellia Therapeutics had its price target raised by Sanford C. Bernstein from $13.00 to $17.00. They now have […]

A number of firms have modified their ratings and price targets on shares of Vor Biopharma (NASDAQ: VOR) recently: 5/18/2026 – Vor Biopharma had its “buy” rating reaffirmed by HC Wainwright. They now have a $31.00 price target on the stock. 5/16/2026 – Vor Biopharma was downgraded by Wall Street Zen from “hold” to “sell”. […]

Several brokerages have updated their recommendations and price targets on shares of Humacyte (NASDAQ: HUMA) in the last few weeks: 5/16/2026 – Humacyte was upgraded by Wall Street Zen from “strong sell” to “sell”. 5/13/2026 – Humacyte had its price target lowered by BTIG Research from $3.00 to $2.00. They now have a “buy” rating […]

Moderna (NASDAQ: MRNA) has recently received a number of price target changes and ratings updates: 5/4/2026 – Moderna had its price target raised by UBS Group AG from $36.00 to $45.00. They now have a “neutral” rating on the stock. 5/4/2026 – Moderna had its price target raised by Royal Bank Of Canada from $35.00 […]

Several brokerages have updated their recommendations and price targets on shares of EastGroup Properties (NYSE: EGP) in the last few weeks: 5/5/2026 – EastGroup Properties had its price target raised by Truist Financial Corporation from $205.00 to $215.00. They now have a “buy” rating on the stock. 4/29/2026 – EastGroup Properties had its price target […]

Several brokerages have updated their recommendations and price targets on shares of Merck & Co., Inc. (NYSE: MRK) in the last few weeks: 5/16/2026 – Merck & Co., Inc. was downgraded by Wall Street Zen from “buy” to “hold”. 5/15/2026 – Merck & Co., Inc. was downgraded by Weiss Ratings from “hold (c+)” to “hold […]

Research Analysts’ price target changes for Tuesday, May 19th: AutoCanada (TSE:ACQ) had its price target cut by ATB Cormark Capital Markets from C$22.00 to C$21.00. The firm currently has a sector perform rating on the stock. Bird Construction (TSE:BDT) had its price target boosted by Canadian Imperial Bank of Commerce from C$52.00 to C$61.00. Bird […]

AutoCanada (TSE:ACQ – Get Free Report) had its price objective dropped by ATB Cormark Capital Markets from C$22.00 to C$21.00 in a note issued to investors on Tuesday,BayStreet.CA reports. The brokerage currently has a “sector perform” rating on the stock. ATB Cormark Capital Markets’ target price would indicate a potential upside of 0.91% from the […]